Preview
Science Corporation received CE mark under the EU Medical Device Regulation from DEKRA and launched commercial availability of its PRIMA subretinal photovoltaic BCI implant across 30 European countries. Clinical trials showed 80% of patients achieved…
The complete summary, “why it matters” analysis and the original source link are available to members.
BCINeural ImplantVisionClinical Trial